Multiple Sclerosis International / 2015 / Article / Fig 2

Research Article

Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study

Figure 2

Kaplan-Meyer plot of cumulative proportion of patients remaining free from relapse by prior exposure to natalizumab over time from start of fingolimod therapy.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.